Elizabeth Fleming

Elizabeth Fleming

Auto-generated profile, based on publicly available information

Elizabeth Fleming

The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2022 in Nature Aging
Verified
Journal Article
Closed access
PDF file
PLPeter J. Larson
Peter J. Larson
WZWei Zhou
Wei Zhou
ASAlba Santiago
Alba Santiago
SDSarah Driscoll
Sarah Driscoll
EFElizabeth Fleming
Elizabeth Fleming
JOJulia Oh
Julia Oh

4 April 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
AVAnita Y. Voigt
Anita Y. Voigt
AEAkintunde Emiola
Akintunde Emiola
JJJethro S Johnson
Jethro S Johnson
EFElizabeth S. Fleming
Elizabeth S. Fleming
HNHoan Nguyen
Hoan Nguyen
JOJulia Oh
Julia Oh

1 January 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PLPeter J. Larson
Peter J. Larson
DCDerrick Chong
Derrick Chong
EFElizabeth Fleming
Elizabeth Fleming
JOJulia Oh
Julia Oh

20 May 2021 in Research Square
Verified
Preprint
Open access
PDF file
MSMichelle Spoto
Michelle Spoto
EFElizabeth Fleming
Elizabeth Fleming
YNYvette Ondouah Nzutchi
Yvette Ondouah Nzutchi
CGChanghui Guan
Changhui Guan
JOJulia Oh
Julia Oh
Staphylococcus (S.) epidermidis is a ubiquitous human commensal skin bacterium and prevalent nosocomial pathogen, but genetic factors underlying this lifestyle plasticity are incompletely understood. We developed a large-scale CRISPR interference (CRISPRi) screen complemented by transcriptional profiling (RNA-seq) across 24 conditions and piloted droplet-based CRISPRi. We identified putative essential genes, demonstrated the importance of trace metal uptake under stress, and identified condition-specific essential genes. Additionally, we demonstrate the considerable transcriptional plasticity of S. epidermidis, postulating a mechanism by which nitrogen metabolism is linked to lifestyle versatility in response to hyperosmotic challenges, and performed a comprehensive analysis of survival under acid stress, hypothesizing a role for cell wall modification as crucial. This study represents one of the first large-scale CRISPRi studies in prokaryotes and the first to integrate transcriptomics data across multiple conditions. Our results provide a valuable benchmarking analysis for CRISPRi screens and are rich resource for other staphylococcal researchers.

28 April 2025 in Blood Advances
Verified
Journal Article
Open access
ACAdela R. Cardones
Adela R. Cardones
AEAkintunde Emiola
Akintunde Emiola
RHRussell P. Hall
Russell P. Hall
ASAnthony D. Sung
Anthony D. Sung
JZJennifer Zhang
Jennifer Zhang
JOJulia Oh
Julia Oh
Gut dysbiosis is linked to mortality and the development of graft-versus-host disease after hematopoietic stem cell transplantation (HSCT), but the impact of cutaneous dysbiosis remains unexplored. We performed a pilot observational study, obtained retroauricular and forearm skin swabs from 12 adult patients before conditioning chemotherapy/radiation and at 1 week, 1 month, and 3 months after allogeneic HSCT, and performed shotgun metagenomic sequencing. The cutaneous microbiome among HSCT patients was enriched for gram-negative bacteria such as Escherichia coli and Pseudomonas, fungi, and viruses. Enrichment with bacteriophages and Polyomavirus species was observed among patients who died within 1 year. We observed longitudinal stability of the cutaneous microbiome at the 3-month time point among those who survived beyond 1 year after HSCT, although these may simply be a reflection of the overall medical status of the patients. There was no association with fungal abundance and any of the outcomes observed. The cutaneous microbiome may be a reservoir of pathobionts among allogeneic HSCT patients. Our findings suggest that cutaneous dysbiosis exists after HSCT, but the ultimate implication of this to patient outcomes remains to be seen through larger studies.